Atriale_fibrillasie%D8%B1%D8%AC%D9%81%D8%A7%D9%86_%D8%A3%D8%B0%D9%8A%D9%86%D9%8AQulaqc%C4%B1qlar%C4%B1n_fibrilyasiyas%C4%B1Fibril%C2%B7laci%C3%B3_auricularCategory:Atrial_fibrillationFibrilace_s%C3%ADn%C3%ADVorhofflimmern%CE%9A%CE%BF%CE%BB%CF%80%CE%B9%CE%BA%CE%AE_%CE%BC%CE%B1%CF%81%CE%BC%CE%B1%CF%81%CF%85%CE%B3%CE%AEAtrial_fibrillationFibrilaci%C3%B3n_auricularAurikulako_fibrilazio%D9%81%DB%8C%D8%A8%D8%B1%DB%8C%D9%84%D8%A7%D8%B3%DB%8C%D9%88%D9%86_%D8%AF%D9%87%D9%84%DB%8C%D8%B2%DB%8CEteisv%C3%A4rin%C3%A4Fibrillation_atrialeFibrilaci%C3%B3n_auricular%D7%A4%D7%A8%D7%A4%D7%95%D7%A8_%D7%A2%D7%9C%D7%99%D7%95%D7%AA%E0%A4%85%E0%A4%B2%E0%A4%BF%E0%A4%82%E0%A4%A6_%E0%A4%B5%E0%A4%BF%E0%A4%95%E0%A4%AE%E0%A5%8D%E0%A4%AA%E0%A4%A8%D5%86%D5%A1%D5%AD%D5%A1%D5%BD%D6%80%D5%BF%D5%A5%D6%80%D5%AB_%D6%86%D5%AB%D5%A2%D6%80%D5%AB%D5%AC%D5%B5%D5%A1%D6%81%D5%AB%D5%A1Fibrilasi_atrialG%C3%A1ttatifFibrillazione_atriale%E5%BF%83%E6%88%BF%E7%B4%B0%E5%8B%95%EC%8B%AC%EB%B0%A9%EC%84%B8%EB%8F%99Fibrillatio_atrialisV%C3%B6rhofffladdernBoezemfibrillerenAtrieflimmer%E0%AC%86%E0%AC%9F%E0%AD%8D%E0%AC%B0%E0%AC%BF%E0%AC%86%E0%AC%B2_%E0%AC%AB%E0%AC%BF%E0%AC%AC%E0%AD%8D%E0%AC%B0%E0%AC%BF%E0%AC%B2%E0%AD%87%E0%AC%B8%E0%AC%A8Migotanie_przedsionk%C3%B3w%D8%A2%D8%AA%D8%B1%D9%8A%D8%A7%D9%84_%D9%81%DB%90%D8%A8%D8%B1%DB%90%D9%84%DB%90%D8%B4%D9%86Fibrila%C3%A7%C3%A3o_auricularFibrila%C8%9Bie_atrial%C4%83%D0%A4%D0%B8%D0%B1%D1%80%D0%B8%D0%BB%D0%BB%D1%8F%D1%86%D0%B8%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%81%D0%B5%D1%80%D0%B4%D0%B8%D0%B9Fibril%C3%A1cia_predsien%C3%ADAtrijska_fibrilacijaFibrilacioni_atrial%D0%A4%D0%B8%D0%B1%D1%80%D0%B8%D0%BB%D0%B0%D1%86%D0%B8%D1%98%D0%B0_%D1%81%D1%80%D1%87%D0%B0%D0%BD%D0%B8%D1%85_%D0%BF%D1%80%D0%B5%D1%82%D0%BA%D0%BE%D0%BC%D0%BE%D1%80%D0%B0F%C3%B6rmaksflimmerMapigo_yasiyo_ya_kawaida_ya_moyoAtriyal_fibrilasyon
about
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular EventsEfficacy and Safety of MAA868 in Patients With Atrial FibrillationFactor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational RegistryPatient Convenience StudyAblation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial FibrillationTactiCath Contact Force Ablation Catheter Study for Atrial FibrillationAVAI: Atrial Ventricular Arrythmia IncidenceRate Control Versus Rhythm Control For Postoperative Atrial FibrillationTactiCath® Prospective Effectiveness Pilot StudyRELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic StrokeIs Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?Salts of Clopidogrel: Investigation to ENsure Clinical EquivalenceSternal ECG Patch Comparison TrialThe Validation of the FibriCheck Application for the Detection of Atrial FibrillationMulti-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)Biological Bank for Atrial Fibrillation and StrokeAtrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-upArcticLine Feasibility StudyTargeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPROThe Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial FibrillationConcomitant Surgical Atrial Fibrillation Ablation in Double Valve ReplacementComparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationStart or STop Anticoagulants Randomised Trial (SoSTART)Long-term Safety in Atrial Fibrillation PatientsExplorative Study of AZD1305 in Atrial Fibrillation PatientsCatheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AFA Phase III Study of Apixaban in Patients With Atrial FibrillationEfficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial FibrillationEfficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationImpact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke IncidenceModeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingInhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass GraftingStudies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.Prevention of Atrial Fibrillation Following EsophagectomySilent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF PatientsTreatment of Atrial Fibrillation by Minimal Invasive SurgeryDirect Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial FibrillationFish Oil for Reduction of Atrial Fibrillation After Cardiac SurgeryKONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation
P1050
aspirindabigatran etexilateedoxabanfondaparinuxdofetilideibutilidewarfarindronedarone(RS)-metoprololamiodaroneclopidogrelverapamilatenololquinidinecarvedilolsotalolapixabanprocainamidedabigatranrivaroxabanflecainidedigoxindiltiazemdigitoxindisopyramideBisoprolol / Hydrochlorothiazidedeslanosidepropafenoneatenolol/chlorthalidone
P2175
Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trialMutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillationDabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of SubgroupsThe Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex InterplayMeta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationAn economic model of adverse events and costs for oral anticoagulants used for atrial fibrillationEarly-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortalityEfficacy and safety of ablation for patients with non-paroxysmal atrial fibrillationVitamin C for treating atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationConcomitant atrial fibrillation surgery for people undergoing cardiac surgeryThe use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationNew oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney diseaseExercise-based cardiac rehabilitation for adults with atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationDirect thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationFactor Xa Inhibitors: A Step Forward in the Treatment of Atrial Fibrillation?Catheter ablation for paroxysmal and persistent atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationDirect thrombin inhibitors and factor Xa inhibitors for atrial fibrillationRhythm control versus rate control for atrial fibrillation/flutterSurgical ablation for atrial fibrillationThe use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationInterventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationDirect thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with non-valvular atrial fibrillationInterventions for the prevention of postoperative atrial fibrillation in adult patients undergoing noncardiac thoracic surgeryOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationSurgical ablation for atrial fibrillationRhythm control versus rate control for atrial fibrillation/flutterAntiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacksAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationCatheter ablation for paroxysmal and persistent atrial fibrillationOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
P921
Q288786-a91f7dfe-48e6-94e5-7bea-1eaf051d94e1Q59276346-88e33525-4d0b-d8b3-5135-515766134aecQ61862220-534EB5FE-4BA9-4560-ACFC-9D4D3F42EE0DQ61862230-79907B2C-3D74-4D45-9EFF-43A68D167E2EQ61862265-71C6F20B-8448-430E-90F5-14877CCA5714Q61864924-C72B2435-D679-45EA-BDC6-E17C81E35FFDQ61865075-476F0C28-D41B-4AB4-A9F3-CCE7CBAF1B3FQ61894217-73AD2C57-DC05-4BF6-BFDE-2BE80F0921CCQ61894331-8D67E030-3013-44F0-80D5-76493117807FQ61894438-3EF5D99E-8CC3-4717-A97D-3A860D5F8939Q61894445-DF937F90-DC51-4859-AD61-E45A91844290Q61894669-CBA90F71-C758-4D1C-B4BA-36FEE93F8406Q61894695-BFBA69B3-9587-4298-B64E-73841996A1CAQ61902665-D5655956-083B-4084-990B-92B3B6BF2778Q61905042-CFC5919B-07EA-4FF2-9DA0-52E39881B2D6Q61906754-9E1B298A-C6FD-476A-A696-837764802AEEQ61907158-1192FF6E-6B87-4EE3-94F3-1D5EA1EFD9F9Q61907416-D2C87221-BFC6-4560-9D73-8359252C0300Q61907448-9648585D-DB8E-4E10-A605-4B05A15B718BQ61907534-87FA45CB-3477-4FDA-9187-A9360B9C0DD1Q61908894-9CE0FBFE-6F8E-4EB3-866E-B5AC95052FF5Q61908968-DE769203-CFA4-4E15-ACEE-3EC40501A0EBQ61909130-4DACAED7-ED98-4DDD-9BAD-6772BF2D2A74Q61909847-0339C233-3499-41A6-B019-CAC88FAA1BC5Q61914392-3F739562-80C3-4FE0-923D-27A1823C20B5Q61914624-FB27810A-EDF7-4C88-93AF-97F2EE70D3BBQ61914651-F97CC43E-9254-461B-A2E4-2F56DB8C9ACEQ61917462-5970A667-3C7D-4AA3-9D63-042657DA9279Q61917625-BFE36C65-D021-40F9-9611-6B7A0774E882Q61918119-A1BCCEE1-E487-4533-A6FE-A57318C708BAQ61918383-D89FD87B-FF1F-4FFC-91E1-8411909278B3Q61918583-35944D72-D231-46B5-88D4-D39CDFAB8861Q61918587-EF55C73A-7F86-41E7-8F2B-0E4589BF9412Q61921150-968CA0F2-F249-41A7-B38D-0E34B4A19137Q61922014-554B38E1-33B0-440C-B0E0-28AACF83A23EQ61922535-57190D1B-37FB-4592-BEE3-56EE901DB149Q61923312-B825D961-10CC-4E6F-96A4-F272009A03DDQ61923950-8CB61128-268B-47F0-AF9C-5D0F6CFBB374Q61924369-118F76D6-10C8-4722-B643-94A4F83178A0Q61933565-34CDBFEC-B461-4055-934F-043BDBD041F4
P1050
Q18216-D7264431-B9F9-4860-9A20-59B2FB04CD7AQ20078502-00FDD771-13DC-4749-BCC3-574428ECBB93Q21011234-8CCB252E-6D99-4D6F-85E1-A1A1D1B7DDD0Q27077698-A6193B27-550C-4770-AC14-EEF2DA6DF8CDQ3712521-BAE68826-AE3C-4849-968F-3906409AAB19Q3791612-2046B7A9-88A9-46F5-8340-C02E2E04A0B9Q407431-183DFF15-3260-4604-9D92-FC762CE2D446Q408637-0D77EF61-025C-40FF-8962-0285E44348A8Q409468-C7068E78-9F1A-4DC9-8E8B-FDDF565C77B4Q410061-33267F12-65B8-4CAD-B7DF-4F133C03A343Q410237-B22C65A2-7FF0-4BAA-B115-6C2154356771Q410291-112C387C-9CD1-4791-8AAC-DBE80BE73CABQ411325-A9952939-B61C-4D50-9AEB-7EEE802810F1Q412496-97D2FB18-0AED-4EAA-943B-FC21E7DCA4CCQ412534-7EC99FBC-92DA-4169-B6CE-BCF37EE5CBB4Q413591-4FC96928-4500-4ACB-8A91-2342AD217C04Q414462-DF4BCCE5-1C95-44AE-B014-4F1CF9644F1FQ417597-B7B6A7E9-ADF3-4908-9B21-AE5DB154E999Q419345-8EE27344-C8EB-4D36-A45C-BF47749A3DE1Q420262-7F498F88-4E07-4299-A8FD-837E2238ABABQ421381-BF2ECA7B-9F5C-4177-AE04-7B545389C693Q422222-6338BCC3-9176-4D1B-A067-0E81A8DA66F2Q422229-2B7D28AA-2A08-4FCA-B48A-01FE72520B25Q423890-66002805-505F-48E8-A116-6E390B5F1CF9Q425120-725726B6-8B3F-4ABF-AC20-DB07E8BD613CQ48566757-E0FE0F26-1F3A-4B75-AA9A-B980532530B4Q5264583-5E696F85-41E7-4EE6-B669-E62BB7DB7B78Q662511-EBDD8B85-AA5A-428B-8DE8-503F2A15AF6BQ7700570-46BEE1E7-ADB9-4A27-97D7-F03DC1BB6857
P2175
description
Krankheit
@de
abnormal heart rhythm characterized by rapid and irregular beating
@en
ac/fa
@fr
alterazione del ritmo cardiaco (aritmia) ad origine dagli atri del cuore
@it
harehjerte
@nb
sydämen nopea rytmihäiriö
@fi
مرض يصيب الإنسان
@ar
name
Atriale fibrillasie
@af
Atrijska fibrilacija
@sl
Atriyal fibrilasyon
@tr
Aurikulako fibrilazio
@eu
Boezemfibrilleren
@nl
Eteisvärinä
@fi
Fibrilacioni atrial
@sq
Fibrilación auricular
@es
Fibrilación auricular
@gl
Fibrilasi atrial
@id
type
label
Atriale fibrillasie
@af
Atrijska fibrilacija
@sl
Atriyal fibrilasyon
@tr
Aurikulako fibrilazio
@eu
Boezemfibrilleren
@nl
Eteisvärinä
@fi
Fibrilacioni atrial
@sq
Fibrilación auricular
@es
Fibrilación auricular
@gl
Fibrilasi atrial
@id
altLabel
A-fib
@en
AF
@en
AFib
@en
Absolute Arrhythmie
@de
Arrhythmia absoluta
@de
Atrial fibrillation
@ar
Atrieflimmer
@sv
Atriumfibrilleren
@nl
Fibrilacion atrial
@es
Fibrilacion auricular
@es
prefLabel
Atriale fibrillasie
@af
Atrijska fibrilacija
@sl
Atriyal fibrilasyon
@tr
Aurikulako fibrilazio
@eu
Boezemfibrilleren
@nl
Eteisvärinä
@fi
Fibrilacioni atrial
@sq
Fibrilación auricular
@es
Fibrilación auricular
@gl
Fibrilasi atrial
@id
P2176
P2293
P2888
P492
P227
P2581
P349
P486
P508
P6366
P646
P1417
science/atrial-fibrillation